Families of transgender adolescents in New York City say Mount Sinai recently told them the health system is pausing youth gender‑affirming care. Parents reached by local reporters described phone calls and emails saying the program would no longer accept new patients and that some ongoing services were being curtailed. Mount Sinai did not respond to requests for comment, and the hospital has not offered a public explanation or timeline.
What happened
– Who: parents of transgender teens and the Mount Sinai health system.
– What: families report a halt to new referrals and restrictions on some existing patients’ access.
– Where: New York City.
– When: notifications were described as recent.
– Why: the hospital has not explained the change, leaving the reasons unclear.
Why continuity matters
Clinical research links timely, uninterrupted gender‑affirming care to better mental‑health outcomes for transgender youth. Providers and advocates warn that sudden interruptions—missed appointments, postponed monitoring, or gaps in hormone therapy—can increase anxiety, undermine treatment plans and complicate medical management. For patients, maintaining steady care often determines whether young people stay engaged with health services at a vulnerable time.
Parents’ accounts and immediate context
Several families said clinic staff contacted them to postpone or cancel visits for adolescents on puberty blockers or gender‑affirming hormones. Some were directed to a general hospital hotline instead of being connected with specialty teams. Parents say written explanations and clear follow‑up plans have been hard to obtain; many are seeking other providers while pressing Mount Sinai for documentation.
This shift comes amid a national reexamination of how hospitals deliver care to transgender minors. Federal statements and actions in some states have increased scrutiny of pediatric gender services, though New York law still permits these therapies for minors. That legal difference leaves families and clinicians in New York navigating a landscape where policy debates, regulatory uncertainty and operational strain collide.
Operational strain and clinical implications
Clinicians emphasize that puberty‑suppressing medications and hormones require coordinated care: dose adjustments, lab monitoring and psychosocial support. Interruptions not only risk physical side effects but also can sever ties to mental‑health resources and the broader multidisciplinary teams that support young patients. Providers contacted by families are reviewing records to arrange safe handoffs where possible, but capacity across the region is limited, raising concerns about how many patients can be absorbed elsewhere.
Legal and policy backdrop
Hospitals nationwide have altered pediatric gender programs as political and regulatory pressure has risen. Earlier federal comments about potential impacts on Medicare and Medicaid funding added to uncertainty for health systems. State responses vary widely: some governors and legislatures have moved to protect clinics, while others have pursued restrictions. That patchwork means families’ access often depends on local legal frameworks and hospital policies rather than a consistent national standard.
New York State response
State officials have reiterated that New York law protects access to care for transgender patients. The Department of Health sent guidance reminding hospitals of nondiscrimination obligations, echoing an advisory from Attorney General Letitia James that denying gender‑affirming treatment to young people could violate state law. The state communication did not create new regulations but stressed that existing protections should guide hospital policies. Officials urged health systems to review protocols, staff training and intake procedures to ensure compliance.
What this means for families and providers
Clear state guidance can help shield services from shifting federal or local pressures by framing gender‑affirming care as nondiscriminatory medical treatment. Still, when programs pause or scale back, families often must search for alternatives—sometimes traveling far from home or facing long waits—which creates logistical, emotional and financial hardship. Experts recommend that hospitals document medical necessity, coordinate with legal counsel and ethics committees, and issue precise departmental guidance so clinicians and families know what to expect.
Looking ahead
Advocacy groups are calling on hospitals to preserve services and communicate transparently with patients when changes are being considered. Clinicians stress that multidisciplinary teams—endocrinology, mental health and primary care—remain the standard for adolescent gender care. Stakeholders also urge systematic monitoring of real‑world data and peer‑reviewed research to understand whether service disruptions affect outcomes and access.
What happened
– Who: parents of transgender teens and the Mount Sinai health system.
– What: families report a halt to new referrals and restrictions on some existing patients’ access.
– Where: New York City.
– When: notifications were described as recent.
– Why: the hospital has not explained the change, leaving the reasons unclear.0
What happened
– Who: parents of transgender teens and the Mount Sinai health system.
– What: families report a halt to new referrals and restrictions on some existing patients’ access.
– Where: New York City.
– When: notifications were described as recent.
– Why: the hospital has not explained the change, leaving the reasons unclear.1